SNDL Sundial Growers Inc

$SNDL I know I’m getting my hopes up but that decision to not RS felt like a huge moment for us. Big things coming! It’s been a long time coming and I’ve been more than paitient!

$SNDL If the buyback prices at the lower end of the proposed range (near the current depressing AF market price), it could remove up to 26.3 million shares—effectively wiping out nearly 10% of SNDL's entire outstanding float in one swift corporate move. 👏

$SNDL DEA MEDICAL REGISTRATION: THE REALITY BEHIND THE HEADLINE 🏛️⚖️ Tom Angell’s report highlights the DEA's strict line in the sand: 1. The 900 Approvals: DEA officially registered >900 medical dispensaries today across 7 medical-only states: FLORIDA, TEXAS, Alabama, Mississippi, South Dakota, Virginia, West Virginia. 2. Why Dual-Use Was Blocked: Under CSA rules, the DEA cannot register dispensaries that co-mingle Schedule I recreational sales with medical under one license ("per se diversion"). 3. Why $SNDL / SunStream Wins: SunStream's 92% Parallel/Surterra footprint is anchored in FLORIDA and TEXAS—both on the DEA's approved list! 4. The Catalyst: This is why Docket No. 1362 (stay ends Nov 5) is critical—the broader rule reschedules all cannabis, bridging adult-use. Florida & Texas medical registrations are live. The thesis holds. 📈🍿 $GTBIF $MSOS $SNDL $TLRY

$SNDL that 921k of volume at 8:40 was the biggest volume spike out of everybody besides ACB at 1.42 million! What does that tell us??

$SNDL All the negative news of RS rumors everyone talked about a few days ago, was just a series of scare tactics to shake off weak hands. Glad I didn't sell💸

$SNDL SEC FILING CONFIRMS 92% PARALLEL TAKEOVER-THE ONLY CANADIAN TICKER + US STAKE. SEC watchers just caught up to SNDL’s Oct 15 release: SNDL officially increased its indirect stake in U.S. operator Parallel from 67% to 92% via a completed rights offering. WHY THIS MATTERS RIGHT NOW: • Near-Total Control: 92% economic ownership locks in 56 dispensaries across FL, TX, & MA, plus the Gainesville cultivation facility. • Revenue Surge: Secures ~$150M USD in high-margin U.S. revenue, lifting SNDL’s pro-forma revenue to ~$829M USD. • Schedule III Timing: Near-complete equity capture positions Parallel for direct Nasdaq balance sheet consolidation once DEA Schedule III codifies. • Valuation Disconnect: $0 parent debt, ~$132M USD cash, record ~C$20M Q3 FCF, and a pending C$50M buyback at $1.35 USD—yet trading at a distressed ~$308M USD cap. This is fresh, actionable news filed this week. SNDL is absorbing a tier-1 U.S. medical footprint at pennies on the dollar. $MSOS $TRLV $GTBIF $TLRY

$SNDL Sedi updated. Another ~443,000 shares bought back and cancelled in second half of Sept.🤙

$SNDL “60 acres in Gainesville”, you say? Is this a reference to the new Surterra/Parallel facility. From LinkedIn:

$SNDL Very interesting week everyone. Good vote result, finally at least some guidance on Parallel (increased ownership), and record FCF guided for upcoming ER. 👍 Have a good weekend, hopefully we bleed back up to pre RS talk SP. 🤙

$SNDL $CURLF If Curlf to buy out SNDL - what will be price per share offer? SNDL is way different than ACB - also assume EUGMP certification for SNDL. $5 - $7 or $10 per share?

$SNDL I can’t help but think SNDL will post an earnings beat for Q3. Between $10M in FCF not related to the insurance and the aggressive share buyback, and still having $10M FCF, I can help but expect both a top line beat and an EPS beat.

$SNDL I jeard from my janitorial friends inside the sndl headquarter that this upcoming earning is the new fresh page for sndl. This company will get re-evaluated and heading into US market with a bang! Also these undercover janitorial staffs been noticing alot of happy employee at sndl lately.

$SNDL Monday November 2 is an important date being the 90-day mark from the expected EU-GMP certification finalized. Not sure what Dan the Man is doing but with the cascade of catalysts incoming that are significant to evolution of SNDL incorporating US assets and achieving regulation - $MSOS inclusion I am expecting and should move forward again.

$SNDL THE ULTIMATE BULL THESIS: SQUEEZING TO $1.35+ 🚀📈 From the $1.22 morning dip straight to $1.34+, smart money is connecting the dots: 1. Florida Medical Clearance: DEA approved 900+ federal Schedule III registrations; 704 were in FLORIDA alone (94.1% of FL queue cleared). SunStream’s 92% Parallel/Surterra footprint (45+ FL stores, ~$150M USD rev) sits on the federally approved side of the DEA firewall. 2. C$50M Buyback Trap: Board authorized C$50M up to $1.35 USD. Retiring 25M–37M shares completely dwarfs the tiny 2.0M share short interest by 15x. 3. Fortress Financials: $0 debt, +C$5.2M real operating income, and a record ~C$20M Free Cash Flow. The GAAP loss was a non-cash paper write-down. 4. Nov 5 Catalyst (48h away): Chief ALJ Julius's stay expires Nov 5, sending Docket 1362 straight to DEA Admin Cole, who proved his signing speed on Centanafadine Oct 28. Dec 11 federal 0.4mg hemp ban wipes out grey-market synthetics. SNDL holds all the cash. 🍿🐸 😉 $MSOS $TRLV $CURLF $GTBIF

$SNDL I am back to feeling semi-bullish after the RS did not go through, we achieved near full ownership of Parallel, and got transparency on Ontario plan. Might be some non-cash impairment noise this quarter but I am atleast happy they acknowledged shareholders and provided some transparency.!

$SNDL President Trump’s December 18, 2025 Executive Order shattered years of federal inertia by demanding agencies expedite the rescheduling process. That direct mandate is exactly what forced the DOJ and DEA to bypass traditional red tape and issue the historic April 2026 order fast-tracking medical marijuana to Schedule III

$SNDL Zach has effectively built a coiled spring. By absorbing default assets at an extreme discount and protecting his capital, he has positioned SNDL to be the ultimate beneficiary when the broader market finally realizes the scale of the SunStream USA device.

$SNDL No R/S yes! After taking over $1B in investor funds and the last R/S, it's time for management to step up and show some net profits to investors.

$SNDL No RS also means no M&A as a buyer untill the stock price recovers above 2-3. This is a good thing - additional M&A would create more long term uncertainly, stock price decay. Let's have few good ERs, S3 and become M&A target instead. 5$ by end of 2027.

$SNDL reverse split was not approved? I am in shock and that is very encouraging and exciting news!